课题基金 / 基金详情

项目摘要

项目成果

Paul D. Bieniasz的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The role and mechanism of action of Vpr (Viral Protein R), an accessory protein encoded by HIV- 1, has been enigmatic for decades. Vpr causes cell cycle arrest at G2/M, triggers a DNA damage response, and enhances viral gene expression. It exerts these activities by targeting host protein(s) for degradation, hijacking cullin4-based E3 ubiquitin ligase complex (CRL4) to induce their depletion. We recently identified a host protein CCDC137, also known as cPERP-B, as a key target protein depleted by Vpr in a CRL4 complex dependent manner. Specifically, CCDC137 depletion by RNA interference recapitulates the aforementioned effects of Vpr on host and virus. In this project we seek to study the molecular details of how CCDC137 represses HIV-1 gene expression as well as how it controls cell cycle progression and the DNA damage response. In Aim 1, we will determine whether CCDC137 depletion is a conserved feature of Vpr proteins from diverse HIV and SIV strains, map the CCDC137 determinants required for Vpr-induced depletion, and assess the effect of Vpr from diverse viruses on viral gene expression. In addition, we will define host proteins required for CCDC137 depletion by Vpr. Aim 2 is centered on the mechanisms of CCDC137-mediated repression of HIV-1 gene expression. We will delineate cis- acting sequences required for CCDC137-mediated repression and evaluate the effect of integration and integration site selection on the Vpr/CCDC137-regulated HIV-1 gene expression. We will also combine screening methods (proteomics, yeast 2-hybrid, and CRISPR functional screens) to identify CCDC137 interacting cofactor(s) to illuminate the mechanism of how CCDC137 inhibits HIV-1 gene expression. In Aim 3 we will investigate how CCDC137 prevents DNA damage response and controls cell cycle progression. In particular, we will determine whether CCDC137 protects chromosomal DNA and delineate host factor(s) cooperating with CCDC137 to modulate the DNA damage response.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Broad neutralization of pandemic threat coronaviruses
  • 批准号:
    10327989
  • 项目类别:
  • 资助金额:
    $642.33万
  • 财政年份:
    2022
  • 负责人:
    Paul D. Bieniasz
  • 依托单位:
Effects of Interferon on primate lentiviruses
  • 批准号:
    10619797
  • 项目类别:
  • 资助金额:
    $71.01万
  • 财政年份:
    2022
  • 负责人:
    Paul D. Bieniasz
  • 依托单位:
Broad neutralization of pandemic threat coronaviruses
  • 批准号:
    10841237
  • 项目类别:
  • 资助金额:
    $425.9万
  • 财政年份:
    2022
  • 负责人:
    Paul D. Bieniasz
  • 依托单位:
Effects of Interferon on primate lentiviruses
  • 批准号:
    10708965
  • 项目类别:
  • 资助金额:
    $70.56万
  • 财政年份:
    2022
  • 负责人:
    Paul D. Bieniasz
  • 依托单位:
海外基金